These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21125964)

  • 1. Quality management benchmarking: FDA compliance in pharmaceutical industry.
    Jochem R; Landgraf K
    Int J Health Care Qual Assur; 2010; 23(8):690-8. PubMed ID: 21125964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2015/2016 Quality Risk Management Benchmarking Survey.
    Waldron K; Ramnarine E; Hartman J
    PDA J Pharm Sci Technol; 2017; 71(5):330-345. PubMed ID: 28512175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International benchmarking and best practice management: in search of health care and hospital excellence.
    von Eiff W
    Adv Health Care Manag; 2015; 17():223-52. PubMed ID: 25985514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical phase inspection process: a benchmarking study in search of industries' best practices.
    Herman DR; Dangler TL; Houser DA; Lewis TG; Masten JL; Taylor IE
    Qual Assur; 1993; 2(1-2):186-90. PubMed ID: 8156211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective executive management in the pharmaceutical industry.
    Tran H; Kleiner BH
    J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schering-Plough agrees to pay FDA $500 million and bring factories into compliance.
    Kuehn BM
    J Am Vet Med Assoc; 2002 Jul; 221(2):174, 180. PubMed ID: 12118571
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of benchmarking seen from the perspective of the Federal Joint Committee (G-BA)].
    Siebig J
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):408-11. PubMed ID: 21767803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benchmarking project spurs better guideline adherence.
    Perform Improv Advis; 2005 Feb; 9(2):20-1, 13. PubMed ID: 15816311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing compliance in production-insights and comparisons in chemical-pharmaceutical companies.
    Rank F; Scheuermann HJ; Wozniewski T; Müller RH
    PDA J Pharm Sci Technol; 2005; 59(4):233-9. PubMed ID: 16218201
    [No Abstract]   [Full Text] [Related]  

  • 11. Corporate compliance programs for FDA-regulated companies: incentives for their development and the impact of the federal sentencing guidelines for organizations.
    Freyer DH
    Food Drug Law J; 1996; 51(2):225-42. PubMed ID: 11820200
    [No Abstract]   [Full Text] [Related]  

  • 12. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond best practices: knowledge management.
    Burns S
    Healthc Benchmarks; 2001 Nov; 8(11):129-31. PubMed ID: 11721618
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of healthcare communications agencies in maintaining compliance when working with the pharmaceutical industry and healthcare professionals.
    Cairns A; Yarker YE
    Curr Med Res Opin; 2008 May; 24(5):1371-8. PubMed ID: 18384708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion alliances: benchmarking and data collection.
    Poole S
    J Infus Nurs; 2010; 33(5):310-5. PubMed ID: 20841985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
    Hewitt NJ; de Kanter R; LeCluyse E
    Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital benchmarking: are U.S. eye hospitals ready?
    de Korne DF; van Wijngaarden JD; Sol KJ; Betz R; Thomas RC; Schein OD; Klazinga NS
    Health Care Manage Rev; 2012; 37(2):187-98. PubMed ID: 21799431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benchmarking HIPAA compliance.
    Wagner JR; Thoman DJ; Anumalasetty K; Hardre P; Ross-Lazarov T
    J Healthc Inf Manag; 2002; 16(2):46-50. PubMed ID: 11941920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing for an FDA preapproval inspection.
    Blackmer RA
    Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.